PAXLOVID
Pfizer Inc.
Mark For: PAXLOVID® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90642654 |
| Registration Number | 6726420 |
| Mark Literal Elements | PAXLOVID |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2021-12-03 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Richard A. Friedman |
| Attorney Docket Number | T 433748 |
Timeline
| 2021-04-13 | Application Filed |
| 2021-04-16 | Location: NEW APPLICATION PROCESSING |
| 2021-04-16 | Status: Live/Pending |
| 2021-04-16 | Transaction Date |
| 2021-12-03 | Location: PUBLICATION AND ISSUE SECTION |
| 2021-12-03 | Status: Review prior to publication completed. |
| 2022-01-11 | Published |
| 2022-05-24 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Pfizer Inc. |
| Address | 66 Hudson Boulevard East New York, NEW YORK UNITED STATES 100012192 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | 2021-04-13 | |
| TEAS Plus New Application | 2021-04-13 | |
| Public Note | 2021-12-02 | |
| XSearch Search Summary | APPLICATION/XML | 2021-12-02 |
| TRAM Snapshot of App at Pub for Oppostn | 2021-12-03 | |
| Notice of Publication | 2021-12-22 | |
| Notification Of Notice of Publication | 2021-12-22 | |
| OG Publication Confirmation | 2022-01-11 | |
| Notice of Allowance | 2022-03-08 | |
| Specimen | 2022-03-08 | |
| Statement of Use | 2022-03-08 | |
| ITU Unit Action | 2022-04-08 | |
| Notice of Acceptance of Statement of Use | 2022-04-08 | |
| TRAM Snapshot of App at Pub for Oppostn | 2022-04-08 | |
| Note To the File | 2022-05-11 | |
| Notice of Registration Email | 2022-05-24 | |
| Registration Certificate | 2022-05-24 |
Attorney of Record
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of infectious and viral diseases and disorders; Pharmaceutical preparations, namely, anti-infective preparations. FIRST USE: 20211224. FIRST USE IN COMMERCE: 20211224
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use |
| GS0051 | Pharmaceutical preparations for the treatment of infectious and viral diseases and disorders; Pharmaceutical preparations, namely, anti-infective preparations |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-03-28 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-03-28 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-03-28 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-03-28 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-03-28 | 88888 |
| REGISTERED-PRINCIPAL REGISTER | 2022-05-24 | |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-05-24 | |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-04-08 | |
| STATEMENT OF USE PROCESSING COMPLETE | 2022-04-07 | 66230 |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-04-07 | |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-04-06 | 66230 |
| USE AMENDMENT FILED | 2022-03-08 | 66230 |
| TEAS STATEMENT OF USE RECEIVED | 2022-03-08 | |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-03-08 | |
| PUBLISHED FOR OPPOSITION | 2022-01-11 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-01-11 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-12-22 | |
| ASSIGNED TO EXAMINER | 2021-12-02 | 91244 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-12-02 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-07-21 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2021-07-21 | |
| NEW APPLICATION ENTERED IN TRAM | 2021-04-16 | |
| NEW APPLICATION ENTERED | 2021-04-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 